David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$410M |
| 2 |
Chevron
CVX
|
+$400M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$381M |
| 4 |
Williams Companies
WMB
|
+$300M |
| 5 |
SLB Ltd
SLB
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$358M |
| 3 |
Biogen
BIIB
|
+$306M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$298M |
| 5 |
Bausch Health
BHC
|
+$298M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 11.89% |
| 2 | Technology | 10.04% |
| 3 | Healthcare | 9.38% |
| 4 | Consumer Discretionary | 8.99% |
| 5 | Industrials | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
General Mills
GIS
$21.3B
| $5.91M | 0.01% |
106,072
+53,761
| +103% | +$3.01M |
|
1327
Theravance Biopharma
TBPH
$884M
| $5.87M | 0.01% |
450,776
+6,745
| +2% | +$105K |
|
1328
The GEO Group
GEO
$4.23B
| $5.84M | 0.01% |
256,622
-181,189
| -41% | -$4.67M |
|
|
MGI
1329
DELISTED
MoneyGram International, Inc. New
MGI
| $5.84M | 0.01% |
635,304
+67,173
| +12% | +$624K |
|
1330
CALL
Lam Research
LRCX
$394B
| $5.83M | 0.01% |
717,000
| – | – |
|
1331
State Street Industrial Select Sector SPDR ETF
XLI
$33.1B
| $5.83M | 0.01% |
+107,900
| New | +$6.05M |
|
|
MM
1332
DELISTED
MILLENNIAL MEDIA INC COM STK (DE)
MM
| $5.8M | 0.01% |
3,578,614
+364,929
| +11% | +$593K |
|
1333
Colgate-Palmolive
CL
$72.8B
| $5.79M | 0.01% |
88,568
+77,348
| +689% | +$5.25M |
|
1334
CALL
Dominion Energy
D
$58.9B
| $5.79M | 0.01% |
86,600
| – | – |
|
|
XNPT
1335
DELISTED
XENOPORT, INC.
XNPT
| $5.79M | 0.01% |
943,968
+49,161
| +5% | +$322K |
|
|
EXL
1336
DELISTED
EXCEL TRUST , INC COM STK
EXL
| $5.78M | 0.01% |
366,558
-119,585
| -25% | -$1.88M |
|
1337
Helmerich & Payne
HP
$4.21B
| $5.78M | 0.01% |
82,019
-17,281
| -17% | -$1.28M |
|
1338
Geron
GERN
$996M
| $5.76M | 0.01% |
1,346,840
+543,096
| +68% | +$2.15M |
|
1339
CALL
Royal Caribbean
RCL
$78.2B
| $5.75M | 0.01% |
73,100
-34,400
| -32% | -$2.62M |
|
1340
Insulet
PODD
$9.92B
| $5.75M | 0.01% |
185,579
-152,134
| -45% | -$4.48M |
|
|
ORBK
1341
DELISTED
Orbotech Ltd
ORBK
| $5.74M | 0.01% |
275,836
-26,649
| -9% | -$515K |
|
1342
CALL
Cummins
CMI
$78.8B
| $5.72M | 0.01% |
43,600
+1,200
| +3% | +$165K |
|
|
UCB
1343
United Community Banks
UCB
$4.23B
| $5.72M | 0.01% |
274,043
+128,061
| +88% | +$2.46M |
|
1344
PUT
Baxter International
BAX
$13.6B
| $5.71M | 0.01% |
150,410
+73,640
| +96% | +$2.75M |
|
|
MDVN
1345
CALL
DELISTED
MEDIVATION, INC.
MDVN
| $5.71M | 0.01% |
100,000
| – | – |
|
|
KATE
1346
DELISTED
Kate Spade & Company
KATE
| $5.7M | 0.01% |
264,542
-98,964
| -27% | -$2.86M |
|
1347
Clearwater Paper
CLW
$351M
| $5.7M | 0.01% |
99,422
+2,817
| +3% | +$174K |
|
1348
CALL
Edwards Lifesciences
EW
$52.4B
| $5.7M | 0.01% |
240,000
| – | – |
|
|
FL
1349
PUT
DELISTED
Foot Locker
FL
| $5.7M | 0.01% |
85,000
| – | – |
|
|
GTS
1350
DELISTED
Triple-S Management Corporation
GTS
| $5.69M | 0.01% |
233,182
+40,136
| +21% | +$852K |
|
Similar funds
David Shaw's Q2 2015 Portfolio in Review
As of Q2 2015, David Shaw held 4,083 positions worth $67.1B, up 2.8% from $65.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw's Q2 2015 filing shows 504 new, 1,541 increased, 1,229 reduced and 364 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $479M.
By sector, the portfolio is most concentrated in Energy at 12% of assets, up from 10% a quarter earlier, followed by Technology and Healthcare.
- David Shaw's largest Q2 2015 buy was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M.
- David Shaw added most to Gilead Sciences in Q2 2015, an estimated $410M increase.
- David Shaw's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $479M.
- David Shaw fully exited TRW AUTOMOTIVE HOLDINGS CORP in Q2 2015, selling an estimated $164M.
- David Shaw's ten largest holdings make up 11% of its $67.1B portfolio in Q2 2015.
- David Shaw opened 504 new positions and closed 364 in Q2 2015.
- David Shaw's portfolio value rose 2.8% quarter-over-quarter to $67.1B.
Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.